title: Counterbalancing forces: what is thrombospondin-1 doing in atherosclerotic lesions?
authors.forename: Olga I
authors.initials: OI
authors.lastname: Stenina
authors.forename: Edward F
authors.initials: EF
authors.lastname: Plow
mesh_terms: D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics; D017209:Apoptosis / Q000235:genetics; D050197:Atherosclerosis / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D001792:Blood Platelets / Q000378:metabolism / Q000473:pathology; D004549:Elastin / Q000235:genetics / Q000378:metabolism; D005838:Genotype; D017737:Macrophages, Peritoneal / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D018345:Mice, Knockout; D032389:Myocytes, Smooth Muscle / Q000378:metabolism* / Q000473:pathology; D009336:Necrosis / Q000378:metabolism / Q000473:pathology; D010587:Phagocytosis / Q000235:genetics; D019700:Thrombospondin 1 / Q000235:genetics
chemical_list: D001057:Apolipoproteins E; D019700:Thrombospondin 1; D004549:Elastin